Statement of Gail Levine, Deputy Director of FTC Bureau of Competition, Regarding the Announcement that Illumina Inc. has Abandoned Its Proposed Acquisition of Pacific Biosciences of California

Following today’s announcement that the parties are abandoning their proposed merger, Gail Levine, Deputy Director of the Bureau of Competition, made this statement: “This deal threatened to let a monopolist extinguish nascent competition in a growing health care market: next-generation DNA sequencing. Customers across the United States and the world will now continue to benefit […]

FTC Challenges Illumina’s Proposed Acquisition of PacBio

The Federal Trade Commission has authorized an action to block Illumina Inc.’s proposed $1.2 billion acquisition of Pacific Biosciences of California (PacBio). The Commission alleges in an administrative complaint (a public version of which will be available and linked to this news release as soon as possible) that Illumina is seeking to unlawfully maintain its […]